Immunochemical properties of anti-Galα1-3Gal antibodies after sensitization with xenogeneic tissues

Journal of Clinical Immunology

Volumn 19, Issue 2, 1999, Pages 116-126

  Yu, Paul B ^a   Parker, William ^a   Everett, Mary Lou ^a   Fox, Ira J ^b   Platt, Jeffrey L ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Anti Gal 1 3Gal; Anticarbohydrate antibodies; Complement; IgG subclass; Natural antibodies

Indexed keywords

ANTIBODY; CARBOHYDRATE ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION; CONTROLLED STUDY; HUMAN; IMMUNOREACTIVITY; LIVER FAILURE; NORMAL HUMAN; PRIORITY JOURNAL; SENSITIZATION; XENOGRAFT;

EID: 0032944909     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020506617105     Document Type: Article

References (53)

1. 1. Boyden SV: Natural antibodies and the immune response. Adv Immunol 5:1, 1964
2. 2. Avrameas S: Natural autoantibodies: From "horror autotoxicus" to "gnothi seauton." Immunol Today 12:154, 1991
3. 3. Casali P, Notkins AL: CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 10:364, 1989
4. 4. Galili U, Rachmilewitz EA, Peleg A, Flechner I: A unique natural human IgG antibody with anti-α-galactosyl specificity. J Exp Med 160:1519, 1984
5. 5. Galili U, Macher BA, Buehler J, Shohet SB: Human natural anti-α-galactosyl IgG: The specific recognition of α(1-3)-linked galactose residues. J Exp Med 162:573, 1985
6. 6. Wiener AS: Origin of naturally occurring hemagglutinins and hemolysins: a review. J Immunol 66:287, 1951
7. 7. Thorbecke GJ: Annu Rev NY Acad Sci 78:237, 1959
8. 8. Galili U, Swanson K: Gene sequences suggest inactivation of α1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc Natl Acad Sci USA 88:7401, 1991
9. 9. Hamadeh RM, Jarvis GA, Galili U, Mandrell RE, Zhou P, Griffiss JM: Human natural anti-gal IgG regulates alternative complement pathway activation on bacterial surfaces. J Clin Invest 89:1223, 1992
10. 10. Galili U, Mandrell RE, Hamadeh RA, Shohet SB, Griffiss JM: Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 56:1730, 1988
11. 11. Rother RP, Fodor WL, Springhorn JP, Birks CW, Setter E, Sandrin MS, Squinto SP, Rollins SA: A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody. J Exp Med 182:1345, 1995
12. 12. Galili U, Flechner I, Knyszynski A, Danon D, Rachmilewitz EA: The natural anti-α-galactosyl IgG on human normal senescent red blood cells. Br J Haematol 62:317, 1986
13. 13. Parker W, Bruno D, Holzknecht ZE, Platt JL: Xenoreactive natural antibodies: isolation and initial characterization. J Immunol 153: 3791, 1994
14. 14. Yu PB, Holzknecht ZE, Bruno D, Parker W, Platt JL: Modulation of natural IgM binding and complement activation by natural IgG antibodies. J Immunol 157:5163, 1996
15. 15. Collins BH, Cotterell AH, McCurry KR, Alvarado CG, Magee JC, Parker W, Platt JL: Hyperacute rejection of cardiac xenografts between primate species: Evidence to support the significance of the α-galactosyl determinant. J Immunol 154:5500, 1995
16. 16. Galili U: Interaction of the natural anti-Gal antibody with a-galactosyl epitopes: A major obstacle for xenotransplantation in humans. Immunol Today 14:480, 1993
17. 17. Good AH, Cooper DKC, Malcolm AJ, Ippolito RM, Koren E, Neethling FA, Ye Y, Zuhdi N, Lamontagne LR: Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 24:559, 1992
18. 18. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IFC: Anti-pig IgM antibodies in human serum react predominantly with Galα(1,3)Gal epitopes. Proc Natl Acad Sci USA 90:11391, 1993
19. 19. Lin SS, Kooyman DL, Daniels LJ, Daggett CW, Parker W, Lawson JH, Hoopes CW, Gullotto C, Li L, Birch P, Davis RD, Diamond LE, Logan JS, Platt JL: The role of natural anti-Galα1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transplant Immunol 5:212, 1997
20. 20. Satake M, Kawagishi N, Rydberg L, Samuelsson B, Tibell A, Groth C, Moller E: Limited specificity of xenoantibodies in diabetic patients transplanted with fetal porcine islet cell clusters. Main antibody reactivity against α-linked galactose-containing epitopes. Xenotransplantation 1:89, 1994
21. 21. Cotterell AH, Collins BH, Parker W, Harland RC, Platt JL: The humoral immune response in humans following cross-perfusion of porcine organs. Transplantation 60:861, 1995
22. 22. Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, Bach FH: Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 52:214, 1991
23. 23. Galili U, Tibell A, Samuelsson B, Rydberg L, Groth CG: Increased anti-gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation 59:1549, 1995
24. 24. Galili U, Minanov OP, Michler RE, Stone KR: High-affinity anti-Gal immunoglobulin G in chronic rejection of xenografts. Xenotransplantation 4:127, 1997
25. 25. Lin SS, Weidner BC, Byrne GW, Diamond LE, Lawson JH, Hoopes CW, Daniels LJ, Daggett CW, Parker W, Harland RC, Davis RD, Bollinger RR, Logan JS, Platt JL: The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 101:1745, 1998
26. 26. Chari RS, Collins BH, Magee JC, Kirk AD, Harland RC, McCann RL, Platt JL, Meyers WC: Treatment of hepatic failure with ex-vivo pig liver perfusion followed by liver transplantation. N Engl J Med 331:234, 1994
27. 27. Platt JL, Turman MA, Noreen HJ, Fischel RJ, Bolman RM, Bach FH: An ELISA assay for xenoreactive natural antibodies. Transplantation 49:1000, 1990
28. 28. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55, 1983
29. 29. Bruggemann M, Williams GT, Bindon CI, Clark MR, Walker MR, Jefferis R, Waldmann H, Neuberger MS: Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 166:1351, 1987
30. 30. Bindon CI, Hale G, Bruggemann M, Waldmann H: Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as Clq. J Exp Med 168:127, 1988
31. 31. Riesen WF, Skvaril F, Braun DG: Natural infection of man with group A streptococci. Levels; restriction in class, subclass, and type; and clonal appearance of polysaccharide-group-specific antibodies. Scand J Immunol 5(4):383, 1976
32. 32. Kraft D, Hedin H, Richter W, Scheiner O, Rumpold H, Devey ME: Immunoglobulin class and subclass distribution of dextran-reactive antibodies in human reactors and non reactors to clinical dextran. Allergy 37(7):481, 1982
33. 33. Umetsu DT, Ambrosino DM, Quinti I, Siber GR, Deha RS: Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 313(20): 1247, 1985
34. 34. Mond JJ, Vos Q, Lees A, Snapper CM: T cell independent antigens. Curr Opin Immunol 7(3):349, 1995
35. 35. Springer GF, Horton RE: Blood group isoantibody stimulation in man by feeding blood group active bacteria. J Clin Invest 48:1280, 1969
36. 36. Sugita M, Moody DB, Jackman RM, Grant EP, Rosat JP, Behar SM, Peters PJ, Porcelli SA, Brenner MB: CD1 - A new paradigm for antigen presentation and T cell activation. Clin Immunol Immunopathol 87(1):8, 1998
37. 37. Fujieda S, Sieling PA, Modlin RL, Saxon A: CD1-restricted T-cells influence IgG subclass and IgE production. J Allergy Clin Immunol 101(4, Pt 1):545, 1998
38. 38. Kay LA: Cellular basis of immune response to antigens of ABO blood-group system. Capacity to provide help during response to T-cell-dependent ABO-system antigens is restricted to individuals of blood group O. Lancet 2(8416):1369, 1984
39. 39. Malyguine AM, Saadi S, Holzknecht RA, Patte CR, Sud N, Platt JL, Dawson JR: Induction of procoagulant function in porcine endothelial cells by human NK cells. J Immunol 159:4659, 1997
40. 40. Auchincloss HJ, Sultan H: Antigen processing and presentation in transplantation. Curr Opin Immunol 8:681, 1996
41. 41. Rydberg L, Breimer ME, Brynger H, Samuelsson BE: ABO-incompatible kidney transplantation (A2 to O). Qualitative and semiquantitative studies of the humoral immune response against different blood group A antigens. Transplantation 49(5):954, 1990
42. 42. Buchs JP, Maillard H, Nydegger U: [Anti-A/B-IgM/G immune response to accidental A-O transfusion and to Toxocara canis infestation]. Schweizerische Medizinische Wochenschrift. J Suisse Med 121(10):347, 1991
43. 43. Ukita M, Takahashi A, Nunotani T, Kihana T, Watanabe S, Yamada N: IgG subclasses of anti-A and anti-B antibodies bound to the cord red cells in ABO incompatible pregnancies. Vox Sanguinis 56(3):181, 1989
44. 44. Silberstein LE, Jefferies LC, Goldman J, Friedman D, Moore JS, Nowell PC, Roelcke D, Pruzanski W, Roudier J, Silverman GJ: Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood 78(9):2372, 1991
45. 45. Mantovani L, Wilder RL, Casali P: Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors. J Immunol 151(1):473, 1993
46. 46. van Es JH, Gmelig Meyling FH, van de Akker WR, Aanstoot H, Derksen RH, Logtenberg T: Somatic mutations in the variable regions of a human IgG anti-double stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus. J Exp Med 173(2):461, 1991
47. 47. Cook AD, Mackay IR, Cicuttini FM, Rowley MJ: IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 24(11):2090, 1997
48. 48. Wu ZQ, Drayton D, Pisetsky DS: Specificity and immunochemical properties of antibodies to bacterial DNA in sera of normal human subjects and patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 109(1):27, 1997
49. 49. McCurry KR, Parker W, Cotterell AH, Weidner BC, Lin SS, Daniels LJ, Holzknecht ZE, Byrne GW, Diamond LE, Logan JS, Platt JL: Humoral responses in pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. Hum Immunol 58:91, 1997
50. 50. Saadi S, Holzkhecht RA, Patte CP, Stern DM, Platt JL: Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 182:1807, 1995
51. 51. Platt JL, Vercellotti GM, Lindman BJ, Oegema TR, Jr., Bach FH, Dalmasso AP: Release of heparan sulfate from endothelial cells: Implications for the pathogenesis of hyperacute rejection. J Exp Med 171:1363, 1990
52. 52. Palmetshofer A, Galili U, Dalmasso AP, Robson SC, Bach FH: Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type I activation. Transplantation 65(6):844, 1998
53. 53. Palmetshofer A, Galili U, Dalmasso AP, Robson SC, Bach FH: Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: Type II activation. Transplantation 65(7):971, 1998